Suppr超能文献

肝硬化内镜检查的安全性。

Safety of Endoscopy in Cirrhosis.

机构信息

Division of Gastroenterology and Hepatology, Brooke Army Medical Center, Fort Sam Houston, TX, USA.

Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

出版信息

Dig Dis Sci. 2024 Sep;69(9):3206-3213. doi: 10.1007/s10620-024-08539-x. Epub 2024 Jul 8.

Abstract

BACKGROUND

Endoscopic procedures are among the most commonly performed medical procedures and the serious adverse event rate is reported to be 1-3 adverse events per 1000 procedures.

AIMS

Here, we have examined the safety of endoscopy specifically in cirrhotic populations.

METHODS

We conducted a retrospective case (cirrhosis)-control (non-cirrhosis) study of the outcomes of patients undergoing endoscopy in a large academic medical center. The primary outcome was a procedural or post-procedural complication. Complete clinical data were collected for all patients undergoing endoscopic procedures-including esophagogastroduodenoscopy, colonoscopy, EUS, ERCP, flexible sigmoidoscopy, and others. Cirrhosis was carefully defined based on clinico-pathological grounds.

RESULTS

We identified 16,779 patients who underwent endoscopy, including 2618 with cirrhosis and 14,161 without cirrhosis. There were 167 complications (0.99%), which included 15/2618 cirrhotics (0.6%) and 152/14,161 (1.1%) non-cirrhotics. The most common complications were cardiopulmonary (including hypotension and hypoxemia) found in 67% of patients; procedurally related complications occurred in 19% of patients. The complication rate was the same or lower in cirrhotics than controls undergoing esophagogastroduodenoscopy (0.6% vs 0.9%, p = 0.03), colonoscopy (0.6% vs. 0.6%, p = NS), or ERCP (0.7% vs. 1.4%, p = NS) Logistic regression analysis identified the following features to be associated with an increased risk of having a complication: inpatient status, history of myocardial infarction, and an EUS procedure.

CONCLUSIONS

Endoscopy in cirrhotic patients was as safe or safer than non-cirrhotic patients undergoing similar procedures.

摘要

背景

内镜检查是最常见的医疗程序之一,据报道,其严重不良事件发生率为每 1000 例 1-3 例不良事件。

目的

在这里,我们专门检查了内镜检查在肝硬化患者中的安全性。

方法

我们对一家大型学术医疗中心进行的内镜检查患者的病例(肝硬化)-对照(非肝硬化)研究结果进行了回顾性分析。主要结果是程序或程序后并发症。对所有接受内镜检查的患者都收集了完整的临床数据,包括食管胃十二指肠镜检查、结肠镜检查、EUS、ERCP、软性乙状结肠镜检查等。根据临床病理依据仔细定义了肝硬化。

结果

我们确定了 16779 名接受内镜检查的患者,其中 2618 名患有肝硬化,14161 名没有肝硬化。有 167 例并发症(0.99%),包括 2618 名肝硬化患者中的 15 例(0.6%)和 14161 名非肝硬化患者中的 152 例(1.1%)。最常见的并发症是心肺并发症(包括低血压和低氧血症),在 67%的患者中发现;程序性相关并发症发生在 19%的患者中。肝硬化患者与接受食管胃十二指肠镜检查(0.6%比 0.9%,p=0.03)、结肠镜检查(0.6%比 0.6%,p=NS)或 ERCP(0.7%比 1.4%,p=NS)的对照组相比,并发症发生率相同或更低。Logistic 回归分析确定以下特征与发生并发症的风险增加相关:住院状态、心肌梗死史和 EUS 检查。

结论

在接受类似程序的肝硬化患者中,内镜检查与非肝硬化患者一样安全或更安全。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验